Preoperative albumin-bilirubin score is a prognostic factor for gastric cancer patients after curative gastrectomy

Table 4 Univariate and multivariate analysis for disease-free survival

Disease-free survival	Univariate			Multivariate
Variables	HR	95%CI	P value	HR	95%CI	P value
Male (vs female)	1.15	0.81-1.61	0.438	-	-	-
Age > 65 yr (vs < 65 yr)	1.18	0.86-1.62	0.312	-	-	-
Charlson > 1 (vs 0)	1.48	1.07-2.04	0.019	1.39	0.94-2.06	0.102
ASA III/IV (vs ASA I/II)	1.84	1.29-2.64	0.001	1.43	0.93-2.21	0.106
Total gastrectomy (vs distal)	1.43	1.04-1.97	0.030	1.43	1.03-1.98	0.031
Diffuse/mixed (vs others)	1.21	0.87-1.67	0.255	-	-	-
pT3/T4 (vs pT1/T2)	2.57	1.76-3.76	< 0.001	2.03	1.33-3.12	0.001
pN+ (vs pN0)	2.26	1.60-3.19	< 0.001	1.54	1.04-2.27	0.030
non-CMT (vs CMT)	1.15	0.83-1.58	0.399	-	-	-
Low-ALBI (vs High-ALBI)	2.09	1.51-2.88	< 0.001	1.83	1.32-2.53	< 0.001

P values in bold are statistically significant. 95%CI: 95% confidence interval; HR: Hazard ratio; ASA: American Society of Anesthesiologists; ALBI: Albumin-bilirubin; pN: Presence of lymph node metastasis; CMT: Chemotherapy.